Molecular genetic and clinical characterization of acute myeloid leukemia with trisomy 8 as the sole chromosome abnormality

References

• Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152.
   PubMed Web of Science ®Google Scholar
• Ley TJ, Miller C, Ding L, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May;368(22):2059–2074.
   PubMed Web of Science ®Google Scholar
• Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom medical research council trials. Blood. 2010 July;116(3):354–365.
   PubMed Web of Science ®Google Scholar
• Lazarevic VL, Rosso A, Juliusson G, et al. Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: a population-based study from the Swedish AML registry. Eur J Haematol. 2017 Jan;98(5):493.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Wei J, Chen Y, et al. Trisomy 8 is the most frequent cytogenetic abnormality in de novo myelodysplastic syndrome in China. Onkologie. 2012 Feb;35(3):100–106.
   PubMedGoogle Scholar
• Yan XF, Wang L, Jiang LX, et al. Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. Cancer Med. 2021 Feb;10(5):1757–1771.
   Web of Science ®Google Scholar
• Such E, Cervera J, Costa D, et al. Cytogenetic risk stratification in chronic myelomonocytic leukemia. Haematologica. 2011 Feb;96:375–383.
   PubMed Web of Science ®Google Scholar
• Wang W, Cortes JE, Lin P, et al. Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in the era of tyrosine kinase inhibitors. Leukemia. 2015 Nov;29(11):2263–2266.
   PubMed Web of Science ®Google Scholar
• Grinfeld J, Nangalia J, Baxter EJ, et al. Classification and personalized prognosis in myeloproliferative neoplasms. N Engl J Med. 2018 Oct;379(15):1416–1430.
   PubMed Web of Science ®Google Scholar
• Mrózek K, Heerema NA, Bloomfifield CD. Cytogenetics in acute leukemia. Blood Rev. 2004 May;18(2):115–136.
   PubMed Web of Science ®Google Scholar
• Hemsing AL, Hovland R, Tsykunova G, et al. Trisomy 8 in acute myeloid leukemia. Expert Rev Hematol. 2019 Aug;12(11):947–958.
   PubMed Web of Science ®Google Scholar
• Yin CC, Cortes J, Barkoh B, et al. T(3;21)(q26;q22) in myeloid leukemia: An aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy. Cancer. 2006 Mar;106(8):1730–1738.
   PubMed Web of Science ®Google Scholar
• Noort S, Zimmermann M, Reinhardt D, et al. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM study group. Blood. 2018 Oct;132(15):1584–1592.
   PubMed Web of Science ®Google Scholar
• Coenen EA, Raimondi S, Harbott J, et al. Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study. Blood. 2011 Sep;117(26):7102–7111.
   PubMed Web of Science ®Google Scholar
• Elliott MA, Letendre L, Hanson CA, et al. The prognostic significance of trisomy 8 in patients with acute myeloid leukemia. Leuk Lymphoma. 2002 Mar;43(3):583–586.
   PubMed Web of Science ®Google Scholar
• Farag SS, Archer KJ, Mrozek K, et al. Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from cancer and leukemia group B 8461. Int J Oncol. 2002 Nov;21(5):1041–1051.
   PubMed Web of Science ®Google Scholar
• Becker H, Maharry K, Mrózek K, et al. Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8. Leukemia. 2014 Aug;28(8):1754–1758.
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 May;127(20):2391–2405.
   PubMed Web of Science ®Google Scholar
• Mccarthy C.. ISCN 2005: An International System for Human Cytogenetic Nomenclature [Book Review]. Australian J Med Sci. 2006;27(4):153.
   Google Scholar
• Wang K, Zhou F, Cai X, et al. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation. Hematology. 2020 May;25(1):211–218.
   PubMed Web of Science ®Google Scholar
• Lin LI, Chen CY, Lin DT, et al. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells. Clin Cancer Res. 2005 Feb;11(4):1372–1379.
   PubMed Web of Science ®Google Scholar
• Chen W, Konoplev S, Medeiros LJ, et al. Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation. Cancer. 2009 Aug;115(23):5481–5489.
   PubMed Web of Science ®Google Scholar
• O’Donnell MR, Tallman MS, Abboud CN, et al. Acute myeloid leukemia, version 3.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017 Jan;15:926–957.
   PubMed Web of Science ®Google Scholar
• Wolman SR, Gundacher H, Appelbaum FR, et al. Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest oncology group study. Blood. 2002 Feb;100(1):29–35.
   PubMed Web of Science ®Google Scholar
• Laursen ACL, Sandahl JD, Kjeldsen E, et al. Trisomy 8 in pediatric acute myeloid leukemia: A NOPHO-AML study. Genes Chromosomes Cancer. 2016 Apr;55(9):719–726.
   PubMed Web of Science ®Google Scholar
• Zong XP, Yao H, Wen LJ, et al. ASXL1 mutations are frequent in de novo AML with trisomy 8 and confer an unfavorable prognosis. Leuk Lymphoma. 2017 Jan;58(1):204–206.
   PubMed Web of Science ®Google Scholar
• Schnittger S, Dicker F, Kern W, et al. RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis. Blood. 2011 Aug;117(8):2348–2357.
   PubMed Web of Science ®Google Scholar
• Tang JL, Hou HA, Chen CY, et al. AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations. Blood. 2009 Oct;114(26):5352–5361.
   PubMed Web of Science ®Google Scholar
• Stengel A, Kern W, Meggendorfer M, et al. Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML. Leukemia. 2018 Feb;32(2):295–302.
   PubMed Web of Science ®Google Scholar
• Alpermann T, Haferlach C, Eder C, et al. AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patients. Leuk Res. 2015 Mar;39(3):265–272.
   PubMed Web of Science ®Google Scholar
• Caligiuri MA, Strout MP, Schichman SA, et al. Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res. 1996 Mar;56(6):1418–1425.
   PubMed Web of Science ®Google Scholar
• Dicker F, Haferlach C, Kern W, et al. Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia. Blood. 2007 May;110(4):1308–1316.
   PubMed Web of Science ®Google Scholar
• Im AP, Sehgal AR, Carroll MP, et al. DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies. Leukemia. 2014 Apr;28(9):1774–1783.
   PubMed Web of Science ®Google Scholar
• Dunlap JB, Leonard J, Rosenberg M, et al. The combination of NPM1, DNMT3A and IDH1/2 mutations leads to inferior overall survival in AML. Am J Hematol. 2019 May;94(8):913–920.
   PubMed Web of Science ®Google Scholar
• Caramazza D, Lasho TL, Finke CM, et al. IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia. Leukemia. 2010 Sep;24(12):2120–2122.
   PubMed Web of Science ®Google Scholar
• Jaff N, Chelghoum Y, Elhamri M, et al. Trisomy 8 as sole anomaly or with other clonal aberrations in acute myeloid leukemia: impact on clinical presentation and outcome. Leuk Res. 2007 Jan;31(1):67–73.
   PubMed Web of Science ®Google Scholar
• Schaich M, Schlenk RF, Al-Ali HK, et al. Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German acute myeloid leukemia intergroup. Haematologica. 2007 May;92(6):763–770.
   PubMed Web of Science ®Google Scholar